Navigation Links
Stem Cell Board Members Should Attend Meetings or Resign, Consumer Group Says

SANTA MONICA, Calif., Aug. 22 /PRNewswire-USNewswire/ -- Frequently facing difficulties mustering a quorum for meetings, California's stem cell oversight board has five members who showed up for 40 percent or fewer of regular board meetings so far this year, an analysis of attendance records by Consumer Watchdog found. The nonpartisan, nonprofit consumer group said members unable to attend regular sessions should step aside to allow people who can participate in deliberations to be appointed.

"Being a member of the Independent Citizens Oversight Committee (ICOC) is hard work and requires a serious commitment," said John M. Simpson, Consumer Watchdog's Stem Cell Project director. "Patients hoping for stem cell cures rightly expect 100 percent commitment by board members. If they can't do that, the fair thing for everyone is to step aside."

The meeting minutes analyzed actually understate the attendance problem because a member is marked present if they are only at part of a session.

"At this month's ICOC meeting Chairman Bob Klein was urging members to act quickly because the board would lose a quorum in 25 minutes. That's no way to make substantive decisions affecting a $6 billion program," said Simpson.

Complicating the task of mustering a quorum is the supermajority required under Proposition 71. Instead of a simple majority, two-thirds, or 19 members, of the 29-person board are required.

This year seven ICOC meetings are scheduled. Six of them are two-day sessions. Five have been held. To help planning for next year, a schedule of the ICOC's regular meetings was posted on the CIRM website Wednesday. It also calls for seven meetings, six of them two-day sessions. This year's meeting schedule was also available far in advance.

"When you know what's expected this far ahead," said Simpson, "there really is no excuse for flagrant absenteeism."

The worst attendance records for the five meetings this year, according to ICOC minutes, are: Marsha Chandler, executive vice president and chief operating officer, Salk Institute, an executive from a California Research Institute (20 percent); Jonathan Shestack, founder & vice president, Cure Autism Now, patient advocate mental health (20 percent); Tina S. Nova, president and CEO of Genoptix, executive officer of a commercial life science entity (40 percent) and Marcy Feit, president and CEO, Valley Care Health Systems, patient advocate Type II Diabetes, (40 percent).

John Reed, president and CEO of the Burnham Institute, an executive officer from a California Research Institute, has attended no meetings since December. He recused himself from all ICOC deliberations pending the outcome of an investigation by the state ethics board into charges that he improperly tried to influence the awarding of a grant to a researcher affiliated with his institute. The investigation by the Fair Political Practices Commission was requested by Consumer Watchdog and State Controller John Chiang.

Under Proposition 71, which created the state stem cell agency, members who hold their seats because they are representatives of universities, research institutes and life sciences entities may designate an executive from their organization to represent them at meetings. There is no provision for patient advocate ICOC members to send a designee. Some academic board members take full advantage of the provision allowing designees to represent them.

Robert Birgeneau, chancellor of UC Berkeley, an executive officer from a California University, has attended no ICOC meetings this year, sending Robert Price in his place. Nonetheless, Consumer Watchdog's analysis credits Birgeneau with 100 percent attendance because his seat on the board was represented at every meeting. Another member taking advantage this ability was Ricardo Azziz, chairman of the Department of Obstetrics and Gynecology at Cedars-Sinai, an executive officer from a California Research Institute, who sent Donald Dafoe to four meetings while attending one himself and half of another.

"With this ability to send a representative, there is no excuse for a seat held by an academic or industry representative to go unrepresented at a meeting that's scheduled at a minimum six months in advance," said Simpson.

Consumer Watchdog analyzed attendance records for all members of the ICOC since 2006. There were six regular meetings in 2006, seven in 2007 and five so far this year. Not included in the analysis were five special meetings conducted by telephone conference call focused on hiring a new president. There were a total of 18 regular meetings over the period analyzed. Not all were members the entire time. Shestack with a 28 percent and Chandler with 43 percent emerged with the worst attendance rate records over the longer time period.

Here's a look at attendance by member (or designee) including the number of meetings they were eligible to attend and the rate of attendance:

Ricardo Azziz -- 14 of 14 -- 100 percent

David Baltimore -- 10 of 10 -- 100 percent

Robert Birgeneau -- 16 of 18 -- 89 percent

Keith L. Black -- 2 of 2 -- 100 percent

Floyd Bloom -- 6 of 6 -- 100 percent

David Brenner -- 11 of 11 -- 100 percent

Susan Bryant -- 17 of 18 -- 94 percent

Marsha Chandler -- 3 of 7 -- 43 percent

Marcy Feit -- 12 of 18 -- 67 percent

Michael Friedman -- 15 of 18 -- 83 percent

Leeza Gibbons -- 5 of 6 -- 83 percent

Michael Goldberg -- 13 of 18 -- 72 percent

Brian E. Henderson -- 14 of 15 -- 93 percent

Edward Holmes -- 4 of 6 -- 67 percent

David Kessler -- 10 of 13 -- 77 percent

Robert Klein -- 18 of 18 -- 100 percent

Sherry Lansing -- 16 of 18 -- 89 percent

Gerald Levey -- 11 of 18 -- 61 percent

Ted Love -- 15 of 18 -- 83 percent

Richard Murphy -- 5 of 10 -- 50 percent

Tina Nova -- 10 of 18 -- 56 percent

Ed Penhoet -- 16 of 18 -- 89 percent

Philip Pizzo -- 17 of 18 -- 94 percent

Claire Pomeroy -- 17 of 18 -- 94 percent

Francisco Prieto -- 15 of 18 -- 83 percent

John Reed -- 9 of 18 -- 50 percent (Recused himself during ethics probe)

Duane Roth -- 16 of 16 -- 100 percent

Joan Samuelson -- 12 of 18 -- 67 percent

David Serrano Sewell -- 15 of 18 -- 83 percent

Jeff Sheehy -- 15 of 18 -- 83 percent

Jonathan Shestack -- 5 of 18 -- 28 percent

Oswald Steward -- 16 of 18 -- 89 percent

Leon Thal -- 6 of 6 -- 100 percent

Janet Wright -- 15 of 15 -- 100 percent

Consumer Watchdog's Stem Cell Oversight and Accountability Project is working to ensure that California's landmark stem cell research program offers accessible and affordable cures and treatments to the taxpayers who have funded it. The program will sell $3 billion in bonds over a decade to fund stem cell research. Financing charges mean the project, the largest source of stem cell research funding in the world, will cost California taxpayers $6 billion.

Consumer Watchdog is California's leading nonprofit and nonpartisan consumer watchdog group. For more information visit us on the web at:

SOURCE Consumer Watchdog
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Sunrise Senior Living Appoints Glyn Aeppel and David Fuente to its Board
2. More Than 1,600 Positions to be Filled at PharmaDiversity Job Board's eJobFair in September
3. Organic Alliance Officially Retracts Announcement on Addition of Dr. Gail Morrison to the Medical Advisory Board
4. The California Board of Registered Nursing Approves Affiliations for Nursing Program in Glendale, California
5. MedQuist Announces Changes to Board of Directors
6. Dr. Jeffrey Rush and Richard Gilchrist Join NHP Board of Directors
7. Bedside Manner, Board Certification Matter: Survey Reveals Top Qualities for Consumers Choosing a Doctor
8. ev3 Inc. Appoints Douglas W. Kohrs to Board of Directors
9. Genoptix Announces the Addition of New Members to Board of Directors
10. Anpath Group, Inc. Announces Appointments of David V. Gilroy and Paul A. Boyer to Board of Directors
11. Dynatronics Elects Mark A. Crockett to its Board of Directors
Post Your Comments:
(Date:11/30/2015)... ... ... The successful filing of an Investigational New Drug application (IND) is a ... key industry segment, Regis Technologies has decided to sponsor and participate in an XTalks-hosted ... , Federal law does not allow new drugs to cross state lines until it ...
(Date:11/30/2015)... ... November 30, 2015 , ... SIMmersion’s ability to present dynamic ... schools of the future. To reach an audience of key visionaries and reformers ... in Chicago, organized by the American Medical Association. , AMA President Steven ...
(Date:11/30/2015)... (PRWEB) , ... November 30, ... ... Service, Inc. are pleased to announce their strategic partnership at the Radiological ... Keystrokes Transcription Service, Inc., and Winscribe, global providers of cutting-edge dictation and ...
(Date:11/30/2015)... ... ... today announced the introduction of three Nightstick® brand LED traffic wands with an average retail ... NSP-1632 ), yellow ( NSP-1634 ) and blue ( NSP-1636 ), the SL-1600 series LED ... in blinking strobe mode using a fresh set of 3 AAA cells (included). , Built ...
(Date:11/29/2015)... ... ... The Cyber Monday deal is a deep 40% or more discount on every item on ... the skin care lover in your circle. Each Christmas, Sublime Beauty offers a special ... serums are staples: Collagen, Retinol and Hyaluronic Serums. , Stocking stuffers like Skin Brushes, natural ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... and SAN DIEGO , Nov. ... Inc. (NASDAQ: ARNA ) today announced that the ... filing the New Drug Application (NDA) for an extended ... formulation will offer patients a chronic weight management treatment ... ) is currently approved as an adjunct to a ...
(Date:11/30/2015)... ST. LOUIS , Nov. 30, 2015  Premera ... today announced an early renewal of the companies, long-standing ... will now extend through at least 2019. ... pharmacy benefit manager capabilities during a competitive review and ... offer the best health plan integration and deliver the ...
(Date:11/30/2015)... N.H. , Nov. 30, 2015 ... that it will feature its latest solutions for ... early identification of cancer at the Radiological Society ... Chicago from November 29 ... recent product advances including iReveal®, an automated breast ...
Breaking Medicine Technology: